在沈阳治湿疹要多少钱啊沈阳看皮肤病那家医院强,沈阳正规医院治灰指甲价格,沈阳治青春痘一般多少钱啊,沈阳治疗狐臭需要多少钱,沈阳哪家医院是痤疮专治医院,沈阳肤康皮肤病医院治疗脱发论坛,沈阳肤康医院腋臭科地址

BEIJING, Sept. 8 (Xinhuanet) -- Middle-aged white women drinking alcohol moderately are more likely to stay healthy than nondrinkers, according to a new study from Harvard.The study has followed about 14,000 mostly white women since 1976.As a result, compared with teetotalers, those who had 3 to 15 alcoholic drinks weekly in their late 50s were 28 percent higher of being free from physical disability, chronic illness, mental health problems, and cognitive decline at the age of 70.Even having just one or two drinks per week increased a woman's odds of good health by 11 percent.However, women should be aware that even moderate drinking has been linked to an increased risk of breast cancer, said Qi Sun, M.D., a lead author of the study and a nutrition researcher at the Harvard School of Public Health.These findings don't necessarily apply to men or to nonwhite women. But they reinforced the evidence for the health benefits of moderate drinking.

CANBERRA, Aug. 3 (Xinhua) -- As many as a quarter of Australian women have experienced some form of assault or sexual abuse, and the higher proportion of the abuse, the higher rates of metal illness a woman tends to suffer from, a new study released on Wednesday found.Researchers from the University of Melbourne and the University of New South Wales conducted the study survey of 4451 Australian women aged 16 to 85. It looked at their experience of the four most common types of gender-based violence - sexual assault, rape, stalking and being badly beaten by their partners.About 15 percent of Australian women report sexual assault, while eight percent report rape, 10 percent said they have a stalker and eight percent report being beaten by their partner.It found strong links between those four types of violence and mental health problems including attempted suicide, posttraumatic stress disorder, panic attacks, depression, anxiety, and substance abuse.Among the women who experienced at least one form of violence, 30 percent had a mood disorder, nearly 40 percent an anxiety disorder, 23 percent were abusing substances and 15 percent were affected by posttraumatic stress syndrome.For the women who suffered higher levels of violence, the rates of anxiety disorders was 77 percent, 52 percent for mood disorders, substance abuse 47 percent and posttraumatic stress syndrome 56 percent.More than six percent of women experienced one form of violent had attempted suicide, compared to 35 percent of women who suffered at least three forms of violence.Public health expert Dr Susan Rees from the University of New South Wales' school of psychiatry, who led the research, said she is especially concerned about the suicide rate of women who are abused."What we found was that there's a high association or a strong association between exposure to gender-based violence and all the three broad classes of mental disorder - so that includes mood, anxiety, substance abuse - and a very high association with attempted suicide," she said in the report released on Wednesday."Women who've not experienced gender-based violence have about a 1.6 percent rate of attempted suicide and that increased to six percent of women who had experienced one type of gender-based violence."She said that gender-based violence was also associated with physical disability, impaired quality of life and a worsening of any existing mental disorders.Dr Rees called for the health care system, particularly psychiatric services, to work closer with women's services to improve support for victims of violence.She added that the federal government also need to underscore the importance of getting to the root cause of the violence against women by looking at attitudes towards women and gender inequality.The study was published in the Journal of the American Medical Association.

WELLINGTON, July 29 (Xinhua) -- Scientists from around the world will gather on the east coast of New Zealand next week to discuss proposals to study "silent" earthquakes by drilling into the seabed.Silent quakes, also known as slow slip events, occur on the boundaries of the earth's tectonic plates, where one plate dives under another in areas known as subduction zones, and are slower than normal quakes, taking weeks or months to occur rather than seconds, and are rarely felt on the surface.About 70 scientists from 10 countries will convene in the city of Gisborne, which lies near the site of a major fault line and where scientists first identified silent earthquakes in 2002.Slow-slip events were first discovered with the advent of new measurement technologies on the west coast of Canada about 15 years ago and have since been recorded at about a dozen locations around the world, including four sites around New Zealand, said a spokesperson for New Zealand's Institute of Geological and Nuclear Sciences (GNS Science).About eight slow-slip episodes have occurred under Gisborne since 2002 at roughly two-year intervals.Scientists have proposed numerous theories to explain the phenomenon, but testing the theories is difficult as silent quakes happen many kilometers below ground."The best way to understand the true cause of slow-slip events is to drill into and sample the area on the plate boundary fault where they are known to occur, and monitor a whole range of physical and chemical properties at the plate interface," said Laura Wallace, of GNS Science.

BEIJING, Sep. 13 (Xinhuanet) --Experts have called for a national drug-control system after a nationwide deficit of a life-saving drug, which has lasted at least three months.Doctors at a Beijing hospital said some specialized hospitals, which perform hundreds of cardiac operations every month, have been paralyzed by their lack of protamine sulfate, which is commonly administered after heart surgery to reverse the anticoagulant effects of heparin.The earliest report of a shortage was in Hubei province on July 21. This was followed by reports of shortages in Guangdong, Shandong and Liaoning provinces.The Shandong newspaper, Qilu Evening News, quoted a regional sales manager, surnamed Zhuang, as saying the province had been allocated 150 doses of protamine sulfate after Shanghai No 1 Biochemical and Pharmaceutical Co Ltd recently resumed production of the drug."But its monthly use here is usually 10,000 doses," he said.The Ministry of Health has denied it is responsible for supplies of the drug and passed the buck to the State Food and Drug Administration, claiming the latter is responsible for the supervision of medicines.Shen Chen, head of the publicity office of the State Food and Drug Administration, said he was unaware of the shortage, but said the administration is responsible for the quality of medicines, not the supply."Development and reform authorities oversee the medicines' prices, while the industrial and commercial authorities oversee the storage. The food and drug departments only cover the approval and quality of medicines."Industry insiders said one of the reasons for the shortage was the low profit margin, which discourages companies from mass producing the drug."Some companies can't earn enough to recover their costs, therefore it is almost impossible to maintain their enthusiasm for continuing production," said Lu Guoping, secretary-general of the Shanghai Pharmaceutical Trade Association.Lu said the government should issue policies to prevent future shortages of such medicines to avoid possible nationwide public health incidents.Yi Shenghua, a lawyer at Beijing Yingke Law Firm, said the country should have a unified system to guarantee the normal supply of medicines that are widely used and drug manufacturers should fulfill their responsibilities to society, even though there is no law stipulating they should produce specific medicines.He came up with two ways to deal with the problem of companies only producing profitable drugs."The government can order businesses to manufacture a certain amount of cheap medicines. Or it can offer financial assistance to subsidize cheap, but life-saving medicines."

MOSCOW, Aug. 30 (Xinhua) -- Russia's space agency said Tuesday that a Proton-M rocket launch failed earlier this month because of a malfunction in the upper stage.The conclusion was reached by an independent investigation commission following a series of checks, Roscosmos said in a report that was posted on its website."The commission reported that the time span reserved for the gyrostabilized platform's turn was miscalculated and narrowed, which caused the Briz-M upper stage's disorientation and the satellite's journey to a wrong orbit," the agency said.Other systems in the upper stage performed well, the agency said, adding it has lifted a ban on launches of the Proton-M carrier rockets equipped with the Briz-M upper stage.Local media reported the Briz-M, manufactured by the Khrunichev State Research and Production Space Center, has had five failures over its 12-year history of operation.On Aug. 18, a Proton-M carrier rocket failed to deliver a communications satellite into orbit. After the failure, Russia suspended launches of Proton-M rockets pending the outcome of an investigation into the failure.